Protective effect of intranasal immunization with Neospora caninum membrane antigens against murine neosporosis established through the gastrointestinal tract

Immunology

Volumn 141, Issue 2, 2014, Pages 256-267

  Ferreirinha, Pedro ^a,b   Dias, Joana ^a   Correia, Alexandra ^a   Pérez Cabezas, Begoña ^a   Santos, Carlos ^a   Teixeira, Luzia ^a   Ribeiro, Adília ^a,b   Rocha, António ^a   Vilanova, Manuel ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antibody responses; CpG DNA; Mucosal immunity; Mucosal vaccines; Parasitology

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; MEMBRANE ANTIGEN; NEOSPORA CANINUM MEMBRANE ANTIGEN; UNCLASSIFIED DRUG; VACCIGRADE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY REACTION; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TRACT; IMMUNE RESPONSE; IMMUNIZATION; MACROPHAGE; MESENTERY LYMPH NODE; MOUSE; NEOSPORA CANINUM; NEOSPOROSIS; NONHUMAN; OPSONIZATION; PARASITE LOAD; PARASITE SURVIVAL; PRIORITY JOURNAL; SPLEEN; TACHYZOITE; TH1 CELL;

ANTIBODY RESPONSES; CPG DNA; MUCOSAL IMMUNITY; MUCOSAL VACCINES; PARASITOLOGY;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, PROTOZOAN; COCCIDIOSIS; CYTOKINES; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NEOSPORA; OLIGODEOXYRIBONUCLEOTIDES;

EID: 84891893462     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12191     Document Type: Article

References (48)

1. Dubey JP, Hattel AL, Lindsay DS, Topper MJ. Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. J Am Vet Med Assoc 1988; 193:1259-63.
2. Dubey JP, Schares G. Neosporosis in animals - the last five years. Vet Parasitol 2011; 180:90-108.
3. Reichel MP, Alejandra Ayanegui-Alcerreca M, Gondim LF, Ellis JT. What is the global economic impact of Neospora caninum in cattle - the billion dollar question. Int J Parasitol 2013; 43:133-42.
4. Reichel MP, Ellis JT. If control of Neospora caninum infection is technically feasible does it make economic sense? Vet Parasitol 2006; 142:23-34.
5. Reichel MP, Ellis JT. Neospora caninum - how close are we to development of an efficacious vaccine that prevents abortion in cattle? Int J Parasitol 2009; 39:1173-87.
6. Miller C, Quinn H, Ryce C, Reichel MP, Ellis JT. Reduction in transplacental transmission of Neospora caninum in outbred mice by vaccination. Int J Parasitol 2005; 35:821-8.
7. Ramamoorthy S, Lindsay DS, Schurig GG, Boyle SM, Duncan RB, Vemulapalli R, Sriranganathn N. Vaccination with γ-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum. J Eukaryot Microbiol 2006; 53:151-6.
8. Bartley PM, Wright S, Chianini F, Buxton D, Innes EA. Inoculation of BALB/c mice with live attenuated tachyzoites protects against a lethal challenge of Neospora caninum. Parasitology 2008; 135:13-21.
9. Williams DJ, Guy CS, Smith RF, Ellis J, Bjorkman C, Reichel MP, Trees AJ. Immunization of cattle with live tachyzoites of Neospora caninum confers protection against fetal death. Infect Immun 2007; 75:1343-8.
10. Liddell S, Jenkins MC, Collica CM, Dubey JP. Prevention of vertical transfer of Neospora caninum in BALB/c mice by vaccination. J Parasitol 1999; 85:1072-5.
11. Ribeiro DP, Freitas MM, Cardoso MR, Pajuaba AC, Silva NM, Mineo TW, Silva JS, Mineo JR, Silva DA. CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice. Vaccine 2009; 27:2570-9.
12. Baszler TV, McElwain TF, Mathison BA. Immunization of BALB/c mice with killed Neospora caninum tachyzoite antigen induces a type 2 immune response and exacerbates encephalitis and neurological disease. Clin Diagn Lab Immunol 2000; 7:893-8.
13. Lunden A, Wright S, Allen JE, Buxton D. Immunisation of mice against neosporosis. Int J Parasitol 2002; 32:867-76.
14. Teixeira L, Marques A, Meireles CS et al. Characterization of the B-cell immune response elicited in BALB/c mice challenged with Neospora caninum tachyzoites. Immunology 2005; 116:38-52.
15. Andrianarivo AG, Rowe JD, Barr BC et al. A POLYGEN-adjuvanted killed Neospora caninum tachyzoite preparation failed to prevent foetal infection in pregnant cattle following i.v./i.m. experimental tachyzoite challenge. Int J Parasitol 2000; 30:985-90.
16. Cannas A, Naguleswaran A, Muller N, Eperon S, Gottstein B, Hemphill A. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology 2003; 126:303-12.
17. Cannas A, Naguleswaran A, Muller N, Gottstein B, Hemphill A. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. J Parasitol 2003; 89:44-50.
18. Pinitkiatisakul S, Mattsson JG, Wikman M, Friedman M, Bengtsson KL, Stahl S, Lundén A. Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms. Vet Parasitol 2005; 129:25-34.
19. Debache K, Guionaud C, Alaeddine F, Mevissen M, Hemphill A. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites. Int J Parasitol 2008; 38:1455-63.
20. Debache K, Alaeddine F, Guionaud C, Monney T, Muller J, Strohbusch M, Leib SL, Grandgirard D, Hemphill A. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites. Int J Parasitol 2009; 39:1373-84.
21. Alaeddine F, Keller N, Leepin A, Hemphill A. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1. J Parasitol 2005; 91:657-65.
22. Tuo W, Zhao Y, Zhu D, Jenkins MC. Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum. Vaccine 2011; 29:2392-9.
23. Debache K, Guionaud C, Alaeddine F, Hemphill A. Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites. Parasitology 2010; 137:229-40.
24. Debache K, Kropf C, Schutz CA et al. Vaccination of mice with chitosan nanogel-associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites. Parasite Immunol 2011; 33:81-94.
25. Debache K, Hemphill A. Differential effects of intranasal vaccination with recombinant NcPDI in different mouse models of Neospora caninum infection. Parasite Immunol 2013; 35:11-20.
26. Teixeira L, Botelho AS, Batista AR et al. Analysis of the immune response to Neospora caninum in a model of intragastric infection in mice. Parasite Immunol 2007; 29:23-36.
27. Correia A, Ferreirinha P, Costa AA et al. Mucosal and systemic T cell response in mice intragastrically infected with Neospora caninum tachyzoites. Vet Res 2013; 44:69.
28. Mineo TW, Benevides L, Silva NM, Silva JS. Myeloid differentiation factor 88 is required for resistance to Neospora caninum infection. Vet Res 2009; 40:32.
29. Hemphill A, Gottstein B. Identification of a major surface protein on Neospora caninum tachyzoites. Parasitol Res 1996; 82:497-504.
30. Zintl A, Pennington SR, Mulcahy G. Comparison of different methods for the solubilisation of Neospora caninum (Phylum Apicomplexa) antigen. Vet Parasitol 2006; 135:205-13.
31. Nishikawa Y, Inoue N, Xuan X, Nagasawa H, Igarashi I, Fujisaki K, Otsuka H, Mikami T. Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection. Vaccine 2001; 19:1381-90.
32. Meeusen EN. Exploiting mucosal surfaces for the development of mucosal vaccines. Vaccine 2011; 29:8506-11.
33. Horton RE, Vidarsson G. Antibodies and their receptors: different potential roles in mucosal defense. Front Immunol 2013; 4:200.
34. Stevens TL, Bossie A, Sanders VM, Fernandez-Botran R, Coffman RL, Mosmann TR, Vitetta ES. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988; 334:255-8.
35. Dubey JP, Schares G, Ortega-Mora LM. Epidemiology and control of neosporosis and Neospora caninum. Clin Microbiol Rev 2007; 20:323-67.
36. Innes EA. The host-parasite relationship in pregnant cattle infected with Neospora caninum. Parasitology 2007; 134:1903-10.
37. Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 2011; 10:499-511.
38. Nishikawa Y, Inoue N, Makala L, Nagasawa H. A role for balance of interferon-γ and interleukin-4 production in protective immunity against Neospora caninum infection. Vet Parasitol 2003; 116:175-84.
39. Jenkins M, Parker C, Tuo W, Vinyard B, Dubey JP. Inclusion of CpG adjuvant with plasmid DNA coding for NcGRA7 improves protection against congenital neosporosis. Infect Immun 2004; 72:1817-19.
40. Hernandez MX, Barcante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40. Immunol Lett 2006; 105:38-47.
41. Rosbottom A, Gibney EH, Guy CS, Kipar A, Smith RF, Kaiser P, Trees AJ, Williams DJ. Upregulation of cytokines is detected in the placentas of cattle infected with Neospora caninum and is more marked early in gestation when fetal death is observed. Infect Immun 2008; 76:2352-61.
42. Omata Y, Terada K, Taka A, Isamida T, Kanda M, Saito A. Positive evidence that anti-Toxoplasma gondii IgA antibody exists in the intestinal tract of infected cats and exerts protective activity against the infection. Vet Parasitol 1997; 73:1-11.
43. Zorgi NE, Costa A, Galisteo AJ Jr, do Nascimento N, Andrade HF Jr. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii. Immunol Lett 2011; 138:187-96.
44. Uchida Y, Ike K, Kurotaki T, Ito A, Imai S. Monoclonal antibodies preventing invasion of Neospora caninum tachyzoites into host cells. J Vet Med Sci 2004; 66:1355-8.
45. Haldorson GJ, Stanton JB, Mathison BA, Suarez CE, Baszler TV. Neospora caninum: antibodies directed against tachyzoite surface protein NcSRS2 inhibit parasite attachment and invasion of placental trophoblasts in vitro. Exp Parasitol 2006; 112:172-8.
46. Zhang H, Compaore MK, Lee EG, Liao M, Zhang G, Sugimoto C, Fujisaki K, Nishikawa Y, Xuan X. Apical membrane antigen 1 is a cross-reactive antigen between Neospora caninum and Toxoplasma gondii, and the anti-NcAMA1 antibody inhibits host cell invasion by both parasites. Mol Biochem Parasitol 2007; 151:205-12.
47. Erbe DV, Pfefferkorn ER, Fanger MW. Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii. J Immunol 1991; 146:3145-51.
48. Fadul CE, Channon JY, Kasper LH. Survival of immunoglobulin G-opsonized Toxoplasma gondii in nonadherent human monocytes. Infect Immun 1995; 63:4290-4.